MoneyWorks4Me

A decent increase of about 45.63% in the sales to Rs. 1623.52 millions was observed for the quarter ended June 2026. The sales figure stood at Rs. 1114.79 millions during the year-ago period.The Total revenue for the quarter ended June 2026 of  Rs. 256.26  millions  grew by 114.75% from Rs. 119.33 millions.Operating Profit saw a handsome growth to 416.44 millions from 245.61 millions in the quarter ended June 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 1623.52 1114.79 45.63 1623.52 1114.79 45.63 5030.59 3701.97 35.89
Other Income 6.23 3.76 65.69 6.23 3.76 65.69 28.59 19.20 48.91
PBIDT 416.44 245.61 69.55 416.44 245.61 69.55 1210.88 823.64 47.02
Interest 26.61 27.60 -3.59 26.61 27.60 -3.59 109.70 98.78 11.05
PBDT 389.83 218.01 78.81 389.83 218.01 78.81 1092.89 724.86 50.77
Depreciation 49.92 47.60 4.87 49.92 47.60 4.87 197.94 182.58 8.41
PBT 339.91 170.41 99.47 339.91 170.41 99.47 894.95 542.28 65.03
TAX 83.65 51.08 63.76 83.65 51.08 63.76 221.46 143.38 54.46
Deferred Tax -2.85 7.49 -138.05 -2.85 7.49 -138.05 -8.87 -15.89 -44.18
PAT 256.26 119.33 114.75 256.26 119.33 114.75 673.49 398.90 68.84
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 25.65 22.03 16.42 25.65 22.03 16.42 24.07 22.25 8.19

Kwality Pharma Share Price

3357.10 -270.15 (-7.45%)
21-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1900.90
Dr. Reddys Labs. 1175.00
Cipla 1426.20
Lupin 2193.00
Zydus Lifesciences 1120.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: